BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14684146)

  • 1. Activation of factor VIII and mechanisms of cofactor action.
    Fay PJ
    Blood Rev; 2004 Mar; 18(1):1-15. PubMed ID: 14684146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutating factor VIII: lessons from structure to function.
    Fay PJ; Jenkins PV
    Blood Rev; 2005 Jan; 19(1):15-27. PubMed ID: 15572214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII structure and function.
    Fay PJ
    Int J Hematol; 2006 Feb; 83(2):103-8. PubMed ID: 16513527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
    Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
    Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
    Hill-Eubanks DC; Lollar P
    J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.
    Neuenschwander PF; Jesty J
    Arch Biochem Biophys; 1992 Aug; 296(2):426-34. PubMed ID: 1632634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
    Regan LM; Fay PJ
    J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
    Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.
    Lamphear BJ; Fay PJ
    Blood; 1992 Dec; 80(12):3120-6. PubMed ID: 1467518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2008 Apr; 283(17):11645-51. PubMed ID: 18299331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
    Donath MS; Lenting PJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
    Buyue Y; Sheehan JP
    Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex.
    Soeda T; Nogami K; Nishiya K; Takeyama M; Ogiwara K; Sakata Y; Yoshioka A; Shima M
    J Biol Chem; 2009 Feb; 284(6):3379-88. PubMed ID: 19047063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C-catalyzed proteolysis of factor VIIIa alters its interactions within factor Xase.
    Regan LM; O'Brien LM; Beattie TL; Sudhakar K; Walker FJ; Fay PJ
    J Biol Chem; 1996 Feb; 271(8):3982-7. PubMed ID: 8626729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A1 and A2 subunits of factor VIIIa synergistically stimulate factor IXa catalytic activity.
    Fay PJ; Koshibu K; Mastri M
    J Biol Chem; 1999 May; 274(22):15401-6. PubMed ID: 10336428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.